Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
Rajabally
Y A
YA
Kass-Hout
T
T
Wilson
P
P
Damian
M S
MS
D001323:Autoantibodies / Q000032:analysis / Q000097:blood; D002169:Campylobacter Infections / Q000150:complications*; D016123:Campylobacter jejuni / Q000276:immunology*; D004568:Electrodiagnosis; D005260:Female; D005732:Gangliosides / Q000276:immunology; D020275:Guillain-Barre Syndrome / Q000150:complications / Q000382:microbiology / Q000503:physiopathology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008875:Middle Aged; D009431:Neural Conduction / Q000276:immunology; D010292:Paresthesia / Q000150:complications / Q000382:microbiology / Q000503:physiopathology*; D010525:Peripheral Nerves / Q000503:physiopathology; D011237:Predictive Value of Tests; D016896:Treatment Outcome
D001323:Autoantibodies; D005732:Gangliosides; D016756:Immunoglobulins, Intravenous; C039129:GQ1b ganglioside